Clinical Trials Insight: 700017406
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2007
At a glance
- Drugs Dulanermin (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Sponsors Aida Pharmaceuticals
- 30 Nov 2007 Status changed from planning to completed.
- 15 Feb 2007 Shanghai Qiaer Biotechnology reported as trial affiliate.
- 02 Nov 2006 New trial record.